Seòmar agus comataidhean

The only precision medicine accepted by the Scottish Medicines Consortium where the companion diagnostic test is not yet offered by NHS Scotland laboratories is Pemigatinib (SMC Number 2399).

We are continuing to work closely with key partners, such as the Scottish Strategic Network for Genomics Medicine (SSNGM), to ensure there is capacity within laboratories for companion diagnostics tests to be offered as soon as practically possible.

The full implementation cost for Digital Evidence Sharing Capability is £33 Million over a 10-year period which is detailed in the full business case. This figure includes supplier costs, storage, and resources from justice partners. DESC will deliver considerable savings of time and cost in the way that evidence is managed and used.

Nobody in our society should ever be subjected to Islamophobia, and we recognise we need to do more to tackle it in Scotland.

We previously consulted with communities affected by Islamophobia on whether adoption of the All-Party Parliamentary Group (APPG) or some other definition of Islamophobia would be helpful. Although communities were broadly supportive of a definition, there was no consensus on the APPG definition.

Our Hate Crime Strategy sets out our strategic priorities for tackling hate crime in Scotland, including Islamophobia. It was informed by communities with lived experience of hate crime, including Muslim communities.

Our Hate Crime Strategy Delivery Plan, published this week, commits to a range of meaningful, ongoing and participatory engagement. We will continue to engage with Muslim communities in Scotland to understand the issues of importance to them as we move into strategy delivery.

The implementation cost of DESC is funded by Scottish Government. There is no cost expected to be paid from Police Scotland or other justice partners existing budget.

When DESC is fully implemented the lifetime management costs of DESC are expected to be met from justice partners, including Police Scotland. The efficiency benefits delivered by DESC are projected to offset these costs.

There has been one case of disciplinary action taken against a Scottish Government employee as a result of a failure to ensure that records are maintained and disposed of in accordance with its record management principles. The disciplinary action was taken in 2018 and the case was dealt with under the minor misconduct procedures.

The Scottish Government is aware that a wide range of views is held by passengers, ScotRail staff and other interested parties, including British Transport Police about alcohol ban on ScotRail trains.

Transport Scotland officials are engaging with British Transport Police, amongst other organisations to ensure that these views are given due consideration.

The NHSScotland Menopause and Menstrual Health Policy launched on 31 October 2023. Whilst the policy was written specifically for NHS Scotland, the supporting resources, including line managers guidance and workplace adjustment guidance, are intended for use more widely across a variety of employment sectors and are available on the National Wellbeing Hub which is accessible to the public.

With the publication of the Policy and Supporting Documents having recently taken place, work can now commence on promoting the policy more widely amongst employers across all sectors.

The Princess Alexandra Eye Pavilion Redevelopment Project, along with a large proportion of live construction projects across the NHS Scotland Estate, is currently on a period of pause, pending a holistic review by Scottish Government of funding availability. NHS Lothian remains in continual communication with Scottish Government to establish when this review will be concluded and when it will be possible to recommence project delivery. This project remains a priority for NHS Lothian, which has a dedicated Project Team mobilised to progress at the earliest opportunity.

The Scottish Government has advised that while they remain committed to the delivery of the new eye hospital, timescales for delivery have still to be determined.

We remain committed to delivering a National Care Service to improve quality, fairness and consistency of provision that meets individuals’ needs. We are designing the NCS in partnership with stakeholders and experts, including NHS management and clinical staff.

The new national shared accountability framework agreed with COSLA and NHS will improve the experience of people accessing services by introducing a new structure of national oversight to drive consistency of outcomes and maximise the benefits of a reformed local service delivery.

The approach agreed provides that local authorities and Health Boards will retain delivery functions, staff and assets. NHS staff will continue to deliver those health services that are in scope for the NCS, together with existing community health providers.

During regional summer co-design sessions, we asked people with lived experience, third sector and statutory stakeholders about how community health services work with social care support and healthcare services. We will use what we have learned during these forums to continue to develop our approach to community healthcare in the NCS and how the National Care Service and NHS should work together.

Officials are engaging with NHS National Services Division (NSD) regularly on the national commissioning of this treatment.

An outline application for the commissioning of a national MRI guided Focussed Ultrasound Service was received from NHS Tayside in March 2023. Subsequent correspondence with NHS Tayside indicated the board was supportive in principle in moving forward with the more detailed planning required to develop a formal specification and proposal.

NHS NSD have encouraged the MRgFUS team in NHS Tayside to submit a formal application for national designation of the MRgFUS service in Dundee, supported by the health board’s Executive Leadership Team, for consideration and scrutiny. NSD hopes to receive such an application from NHS Tayside for 2024-25.